Where Policy Advantage Meets Precision Manufacturing – Your Strategic Gateway to China and Beyond

As Hainan prepares for island-wide customs closure on December 18, 2025, medical device leaders gain unprecedented access to China’s market through three transformative policies:

· Zero-Tariff Expansion: Duty-free imports for 6,600 items (74% of all imported goods), including medical equipment, core components, and advanced materials.

· Value-Added Processing: Products achieving >30% value-add in Hainan enter mainland China tariff-free – reducing end costs by 15–25%.

· Bonded Maintenance: 38 categories of medical equipment eligible for tariff-free repair in Hainan – slashing service costs by >30%.

I. Unlocking Value: How PT MedTech Converts Policy into Your Competitive Edge

1. Cost Transformation Engine
Leverage dual zero-tariff and value-added processing policies:

· Import core components duty-free

· PT MedTech performs high-precision assembly (35%+ value-add)

· Ship tariff-free to Chinese market
Result: 18–25% cost reduction for endoscopic instruments

2. Innovation Acceleration Platform
Integrated "LeCheng R&D → Haikou Production" model:

· Rapid prototyping using real-world data from Boao Lecheng

· Accelerated scale-up under China’s MAH system

· 40% faster market entry with zero factory CAPEX

3. Global Service Hub
PT MedTech’s bonded maintenance solution:

· Duty-free import of faulty equipment

· Precision component repair and recertification

· Re-export at 50% lower operational cost vs. European factory repairs

II. The PT MedTech Advantage: Your Turnkey Global Manufacturing Solution

Why Partner Instead of Building?
While self-building in Hainan requires >$7M CAPEX and 18+ months to production, PT MedTech delivers:

· Zero factory investment

· 90-day production launch

· Instant access to existing FDA/CE/NMPA certifications

· Expert-guided policy compliance (no dedicated team needed)

Unmatched Capabilities:

· Precision Manufacturing: 5-axis femtosecond laser cutting, 128 proprietary tooling systems, ISO Class 7/8 cleanrooms.

· Global Compliance: FDA-registered, CE MDR documentation, NMPA licenses.

· Vertical Integration: End-to-end production accelerating development by 30%.

III. Partnership Models: Immediate Pathways to Value

1. Zero-Tariff Market Entry
For international brands: Duty-free component import → 35%+ value-add assembly → tariff-free China access.
Proven outcome: $780K tariff savings per batch for orthopedic clients.

2. Asset-Light Commercialization
For innovators: 50-unit pilot batches → validation → 100K-unit production.
*Avoid $3M+ factory investment while accelerating time-to-market.*

3. APAC Service Hub
For global service optimization:

· 1-week turnaround (vs. 4 weeks in Europe)

· 67% lower total cost

IV. Seizing the Opportunity: Your Action Plan

PT MedTech removes barriers through:

1. Complimentary Policy-Fit Assessment: Customized savings via Hainan Value Simulator.

2. Fast Prototyping & Flexible Launch: 50-unit MOQ for market testing.

3. Global Compliance: Single-source FDA/CE/NMPA production.

Partner Success:

· German MIS leader: 92% CAPEX reduction, 14-month faster China entry.

· Swiss robotics firm: APAC service costs cut to 1/3.

Time Is Critical: 150 Days Until Customs Closure

Your Choice:
→ Chase fading advantages with $7M+ factory investments
→ Launch in 90 days with PT MedTech and capture immediate savings

Hainan’s value lies in execution – not policy documents. Our four decades of expertise transform clauses into your bottom-line advantage.

Act Now for Strategic Entry to China & ASEAN’s $100B MedTech Market
→ Email info@pt-medtech.com for a professional consultation within 48 hours.

PT MedTech – Your Precision Manufacturing Partner for the Hainan Era
www.pt-medtech.com